Pricing Log in Create free account

Avalo Therapeutics, Inc. (AVTX) vs Zura Bio Limited (ZURA)

Avalo Therapeutics, Inc. and Zura Bio Limited are both Biotechnology companies. Avalo Therapeutics, Inc. and Zura Bio Limited are of similar size ($388.8M and $384.3M). Across the 9 metrics below, Avalo Therapeutics, Inc. leads on 6 and Zura Bio Limited on 3.

Valuation

Metric AVTX ZURA Biotechnology median
P/E n/m n/m 10.64
P/S 254.55 n/m 9.59
P/B 0.71 2.86 2.15
Price to free cash flow n/m n/m 26.07
EV/EBITDA 0.78 n/m 0.65
EV/Sales (57.24) n/m 9.45
Earnings yield (65.26%) (28.20%) (34.69%)
Free cash flow yield (43.84%) (17.05%) (24.02%)

Profitability

Metric AVTX ZURA Biotechnology median
Gross margin 64.72% — 65.59%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (36.27%) (85.05%) (51.96%)
Return on assets (32.50%) (72.21%) (46.06%)
Return on invested capital (118.21%) 0.00% 0.00%

Growth

Metric AVTX ZURA Biotechnology median
Revenue growth (TTM) (92.65%) — 4.59%
EPS growth (last fiscal year) 72.07% (76.67%) 29.88%
Revenue growth, 5-year CAGR (61.19%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AVTX ZURA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 19.31 11.29 4.86
Net debt to EBITDA 1.36 1.45 1.01

Dividend

Metric AVTX ZURA Biotechnology median
Dividend yield — — 0.38%
Payout ratio — — —

Size

Metric AVTX ZURA Biotechnology median
Market cap 388.82m 384.34m 174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack